ANDREA A VENTURINI

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease SATELLITE BEACH, FL NPI 1194919720

General Payments — all program years on this page

$4,075.37

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 117
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $372.49 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $372.4920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $504.6022
2019 $2,048.3132
2020 $152.134
2021 $112.916
2022 $739.1423
2023 $145.7910
2024 $372.4920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087851740 Pulmonx Corporation $30.08 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089563658 Insmed, Inc. $20.72 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089563660 Insmed, Inc. $21.88 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091148668 ANI Pharmaceuticals, Inc. $31.43 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104784482 AstraZeneca Pharmaceuticals LP $13.45 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114236174 Regeneron Healthcare Solutions, Inc. $21.56 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117912704 Boehringer Ingelheim Pharmaceuticals, Inc. $23.83 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117912706 Boehringer Ingelheim Pharmaceuticals, Inc. $29.06 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126060604 HARMONY BIOSCIENCES LLC $22.20 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137915595 Electromed, Inc. $10.96 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137915597 Electromed, Inc. $11.14 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137915599 Electromed, Inc. $11.14 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137915601 Electromed, Inc. $11.14 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137915603 Electromed, Inc. $11.14 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139840097 GENZYME CORPORATION $22.32 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141478960 Harmony Biosciences Llc $10.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147300721 Mylan Specialty L.P. $18.35 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147337976 Mylan Specialty L.P. $16.66 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147341658 Mylan Specialty L.P. $19.05 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149456668 United Therapeutics Corporation $16.38 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.